Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Work In Process (2017 - 2023)

Historic Work In Process for Perspective Therapeutics (CATX) over the last 11 years, with Q1 2023 value amounting to $616000.0.

  • Perspective Therapeutics' Work In Process rose 7352.11% to $616000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $616000.0, marking a year-over-year increase of 7352.11%. This contributed to the annual value of $636000.0 for FY2022, which is N/A changed from last year.
  • As of Q1 2023, Perspective Therapeutics' Work In Process stood at $616000.0, which was up 7352.11% from $636000.0 recorded in Q4 2022.
  • Over the past 5 years, Perspective Therapeutics' Work In Process peaked at $636000.0 during Q4 2022, and registered a low of $114000.0 during Q1 2019.
  • Over the past 5 years, Perspective Therapeutics' median Work In Process value was $240000.0 (recorded in 2020), while the average stood at $306000.0.
  • As far as peak fluctuations go, Perspective Therapeutics' Work In Process tumbled by 2549.02% in 2019, and later surged by 12910.45% in 2022.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Work In Process stood at $166000.0 in 2019, then increased by 26.51% to $210000.0 in 2020, then skyrocketed by 37.14% to $288000.0 in 2021, then surged by 120.83% to $636000.0 in 2022, then fell by 3.14% to $616000.0 in 2023.
  • Its Work In Process was $616000.0 in Q1 2023, compared to $636000.0 in Q4 2022 and $614000.0 in Q3 2022.